Table Of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Drivers

   3. 4.3 Restraints

   4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. Market Segmentation

   1. 5.1 Monitoring Devices

      1. 5.1.1 Self-Monitoring Blood Glucose Devices

         1. 5.1.1.1 By Component (Value and Volume, 2012 - 2024)

            1. 5.1.1.1.1 Glucometer Devices

            2. 5.1.1.1.2 Test Strips

            3. 5.1.1.1.3 Lancets

         2. 5.1.1.2 By End User

            1. 5.1.1.2.1 Hospital (Value and Volume, 2012 - 2024)

               1. 5.1.1.2.1.1 Glucometer Devices

               2. 5.1.1.2.1.2 Test Strips

               3. 5.1.1.2.1.3 Lancets

            2. 5.1.1.2.2 Personal (Value and Volume, 2012 - 2024)

               1. 5.1.1.2.2.1 Glucometer Devices

               2. 5.1.1.2.2.2 Test Strips

               3. 5.1.1.2.2.3 Lancets

      2. 5.1.2 Continuous Blood Glucose Monitoring

         1. 5.1.2.1 By Component (Value and Volume, 2012 - 2024)

            1. 5.1.2.1.1 Sensors

            2. 5.1.2.1.2 Receivers

   2. 5.2 Management Devices

      1. 5.2.1 Insulin Pump

         1. 5.2.1.1 Insulin Pump Device

         2. 5.2.1.2 Insulin Pump Reservoir

         3. 5.2.1.3 Infusion Set

      2. 5.2.2 Insulin Syringes

      3. 5.2.3 Insulin Cartridges

      4. 5.2.4 Disposable Pens

      5. 5.2.5 Jet Injectors

   3. 5.3 Geography

      1. 5.3.1 North America

         1. 5.3.1.1 United States (Value and Volume, 2012 - 2024)

            1. 5.3.1.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.1.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.1.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         2. 5.3.1.2 Canada (Value and Volume, 2012 - 2024)

            1. 5.3.1.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.1.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.1.2.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         3. 5.3.1.3 Rest of North America (Value and Volume, 2012 - 2024)

            1. 5.3.1.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.1.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.1.3.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

      2. 5.3.2 Europe

         1. 5.3.2.1 France (Value and Volume, 2012 - 2024)

            1. 5.3.2.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         2. 5.3.2.2 Germany (Value and Volume, 2012 - 2024)

            1. 5.3.2.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.2.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         3. 5.3.2.3 Italy (Value and Volume, 2012 - 2024)

            1. 5.3.2.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.3.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         4. 5.3.2.4 Spain (Value and Volume, 2012 - 2024)

            1. 5.3.2.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.4.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         5. 5.3.2.5 United Kingdom (Value and Volume, 2012 - 2024)

            1. 5.3.2.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.5.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         6. 5.3.2.6 Russia (Value and Volume, 2012 - 2024)

            1. 5.3.2.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.6.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         7. 5.3.2.7 Rest of Europe (Value and Volume, 2012 - 2024)

            1. 5.3.2.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.2.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.2.7.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

      3. 5.3.3 Latin America

         1. 5.3.3.1 Mexico (Value and Volume, 2012 - 2024)

            1. 5.3.3.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.3.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.3.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         2. 5.3.3.2 Brazil (Value and Volume, 2012 - 2024)

            1. 5.3.3.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.3.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.3.2.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         3. 5.3.3.3 Rest of Latin America (Value and Volume, 2012 - 2024)

            1. 5.3.3.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.3.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.3.3.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

      4. 5.3.4 Asia-Pacific

         1. 5.3.4.1 Japan (Value and Volume, 2012 - 2024)

            1. 5.3.4.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         2. 5.3.4.2 South Korea (Value and Volume, 2012 - 2024)

            1. 5.3.4.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.2.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         3. 5.3.4.3 China (Value and Volume, 2012 - 2024)

            1. 5.3.4.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.3.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         4. 5.3.4.4 India (Value and Volume, 2012 - 2024)

            1. 5.3.4.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.4.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         5. 5.3.4.5 Australia (Value and Volume, 2012 - 2024)

            1. 5.3.4.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.5.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         6. 5.3.4.6 Vietnam (Value and Volume, 2012 - 2024)

            1. 5.3.4.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.6.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         7. 5.3.4.7 Malaysia (Value and Volume, 2012 - 2024)

            1. 5.3.4.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.7.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         8. 5.3.4.8 Indonesia (Value and Volume, 2012 - 2024)

            1. 5.3.4.8.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.8.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.8.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         9. 5.3.4.9 Philippines (Value and Volume, 2012 - 2024)

            1. 5.3.4.9.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.4.9.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.4.9.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         10. 5.3.4.10 Thailand (Value and Volume, 2012 - 2024)

             1. 5.3.4.10.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

             2. 5.3.4.10.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

             3. 5.3.4.10.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         11. 5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 - 2024)

             1. 5.3.4.11.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

             2. 5.3.4.11.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

             3. 5.3.4.11.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

      5. 5.3.5 Middle East & Africa

         1. 5.3.5.1 Saudi Arabia (Value and Volume, 2012 - 2024)

            1. 5.3.5.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         2. 5.3.5.2 Iran (Value and Volume, 2012 - 2024)

            1. 5.3.5.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.2.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         3. 5.3.5.3 Egypt (Value and Volume, 2012 - 2024)

            1. 5.3.5.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.3.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         4. 5.3.5.4 Oman (Value and Volume, 2012 - 2024)

            1. 5.3.5.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.4.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         5. 5.3.5.5 South Africa (Value and Volume, 2012 - 2024)

            1. 5.3.5.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.5.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

         6. 5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 - 2024)

            1. 5.3.5.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)

            2. 5.3.5.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

            3. 5.3.5.6.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, Sanofi, Eli Lilly and Others)

6. 6. MARKET INDICATORS

   1. 6.1 Type 1 Diabetes Population (2012-2024)

   2. 6.2 Type 2 Diabetes Population (2012-2024)

7. 7. COMPETITIVE LANDSCAPE

   1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Bionime Corporation

      10. 7.1.10 Acon

      11. 7.1.11 Medisana

      12. 7.1.12 Trivida

      13. 7.1.13 Rossmax

   2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Johnson & Johnson

      3. 7.2.3 Abbott Diabetes Care

      4. 7.2.4 Dexcom

      5. 7.2.5 Medtronics

      6. 7.2.6 Novo Nordisk

      7. 7.2.7 Eli Lilly

      8. 7.2.8 Sanofi

      9. 7.2.9 Others

8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS